Cargando…

Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005‐2015 show improved survival over time

OBJECTIVES: We aimed to describe treatment patterns of chronic lymphocytic leukaemia (CLL) patients in routine practice settings, compare overall survival and time‐to‐next‐treatment among patients treated in different time periods (2005‐2008, 2009‐2013, 2014‐2015), and explore associated factors. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindström, Vesa, Hakkarainen, Katja M., Mehtälä, Juha, Klement, Riho, Leval, Amy, Järvinen, Tiina M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851967/ https://www.ncbi.nlm.nih.gov/pubmed/31210368 http://dx.doi.org/10.1111/ejh.13273

Ejemplares similares

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)
por: Freeman, Ciara L., et al.
Publicado: (2016)

The Mysterious Actor—γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL)
por: Zarobkiewicz, Michał K., et al.
Publicado: (2022)

The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
por: Van Dyke, Daniel L., et al.
Publicado: (2016)

The association between body mass index groups and metabolic comorbidities with healthcare and medication costs: a nationwide biobank and registry study in Finland
por: Vesikansa, Aino, et al.
Publicado: (2023)

Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease
por: Rubino, Valentina, et al.
Publicado: (2023)

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody
por: Ciszak, Lidia, et al.
Publicado: (2015)

Shielding the Vulnerable: A Multicentre Australian Rollout of Evusheld to Patients with Chronic Lymphocytic Leukaemia (CLL-SHIELD)
por: Whitechurch, Ashley, et al.
Publicado: (2022)

Clustering Diagnoses From 58 Million Patient Visits in Finland Between 2015 and 2018
por: Fränti, Pasi, et al.
Publicado: (2022)

Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia
por: Gao, Rui, et al.
Publicado: (2023)

Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden
por: Hakkarainen, Katja Marja, et al.
Publicado: (2020)

Comorbidity characteristics of multiple myeloma patients diagnosed in Finland 2005–2016
por: Toppila, Iiro, et al.
Publicado: (2022)

Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres
por: Innocenti, Idanna, et al.
Publicado: (2022)

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
por: Egle, Alexander, et al.
Publicado: (2018)

Not all lymphoid aggregates in chronic lymphocytic leukemia (CLL) patients are due to CLL!
por: Mahapatra, Lily, et al.
Publicado: (2021)

Real‐world experience of novel multiple myeloma treatments in a large, single‐center cohort in Finland
por: Loponen, Heidi, et al.
Publicado: (2023)

Declining incidence of acromioplasty in Finland
por: Paloneva, Juha, et al.
Publicado: (2015)

High Toxocara cati prevalence in wild, free-ranging Eurasian lynx (Lynx lynx) in Finland, 1999–2015
por: Virta, Miisa, et al.
Publicado: (2022)

Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B
por: Yoon, J-Y, et al.
Publicado: (2013)

Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients
por: Monti, Paola, et al.
Publicado: (2020)

Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
por: Odetola, Oluwatobi, et al.
Publicado: (2023)

Trends of shoulder instability surgery in Finland: a nationwide register study
por: Joukainen, Antti, et al.
Publicado: (2020)

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013
por: Remes, Kari, et al.
Publicado: (2018)

Policy windows for drug consumption rooms in Finland
por: Unlu, Ali, et al.
Publicado: (2022)

National Health Index shows an increase and marked regional differences in diabetes burden in Finland
por: Jousilahti, P, et al.
Publicado: (2023)

Stimulation by CLL cells in mixed lymphocyte culture (MLC).
por: Jones, E. H., et al.
Publicado: (1981)

Immunological aspects in chronic lymphocytic leukemia (CLL) development
por: García-Muñoz, Ricardo, et al.
Publicado: (2012)

Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL)
por: Sitlinger, Andrea, et al.
Publicado: (2021)

19.3 APPLYING COGNITIVE ADAPTATION TRAINING IN FINLAND: INTERIM RESULTS OF THE FINNISH CAT IMPLEMENTATION PROJECT
por: Mehtala, Tuukka, et al.
Publicado: (2018)

Application of the Environmental Relative Moldiness Index in Finland
por: Täubel, Martin, et al.
Publicado: (2016)

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)

Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure–Response in CLL
por: Gibiansky, E, et al.
Publicado: (2014)

The impact of the COVID-19 pandemic on incident cases of chronic diseases in Finland
por: Wikström, Katja, et al.
Publicado: (2022)

Pharmacological targeting of eIF4E in primary CLL lymphocytes
por: Martinez-Marignac, V, et al.
Publicado: (2013)

Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL)
por: Seymour, Erlene K.
Publicado: (2019)

Filicide in Austria and Finland - A register-based study on all filicide cases in Austria and Finland 1995-2005
por: Putkonen, Hanna, et al.
Publicado: (2009)

Increasing incidence of rotator cuff repairs—A nationwide registry study in Finland
por: Paloneva, Juha, et al.
Publicado: (2015)

Occupational burn injuries in Finland 2011–2015
por: Purola, Lotta, et al.
Publicado: (2022)

Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial
por: Blakemore, Stuart J., et al.
Publicado: (2020)

A Case of Lymphocytic Leukæmia
por: Reynolds, Fredrick H.
Publicado: (1933)

Mode of treatments and achievement of treatment targets among type 2 diabetes patients with different comorbidities – a register-based retrospective cohort study in Finland
por: Nazu, Nazma Akter, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ffgj11dtl2elm3dj6i04therq